The Application Notebook
The procedure involves a rapid and efficient pretreatment with SampliQ QuEChERS kits. The homogenized liver sample was initially extracted in a buffered aqueous/1% acetic acid acetonitrile system with an extraction and partitioning step after the addition of salts. Finally, the sample was cleaned up using dispersive solid-phase extraction (dispersive-SPE). The final extracts were analysed by the sensitive and selective determination of all compounds in a single run using LC–ESI-MS–MS operating in positive ion multiple reaction monitoring (MRM) mode. Sulphapyridine was selected as the internal standard. The accuracy of the method, expressed as recovery, was between 53 and 93%. The precision, expressed as RSD, was between 2.1 and 16.8%. The established 5 ng/g limits of quantification (LOQ) were much lower than the respective maximum residue limit (MRL) for sulphonamide in animal food products (20–100 ng/g).
Limian Zhao and Joan Stevens, Agilent Technologies Inc., Wilmington, Delaware, USA.
The procedure involves a rapid and efficient pretreatment with SampliQ QuEChERS kits. The homogenized liver sample was initially extracted in a buffered aqueous/1% acetic acid acetonitrile system with an extraction and partitioning step after the addition of salts. Finally, the sample was cleaned up using dispersive solid-phase extraction (dispersive-SPE). The final extracts were analysed by the sensitive and selective determination of all compounds in a single run using LC–ESI-MS–MS operating in positive ion multiple reaction monitoring (MRM) mode. Sulphapyridine was selected as the internal standard. The accuracy of the method, expressed as recovery, was between 53 and 93%. The precision, expressed as RSD, was between 2.1 and 16.8%. The established 5 ng/g limits of quantification (LOQ) were much lower than the respective maximum residue limit (MRL) for sulphonamide in animal food products (20–100 ng/g).
Sample preparation and HPLC condtions are available in their entirety within Agilent Technologies publications 5990-5086EN.
Figure 1 shows the MRM chromatograms of the liver control blank and 100 ng/g fortified liver extract. The liver control blank chromatogram indicated that the target analytes were free from any interference.
Figure 1
The recovery and reproducibility (shown as RSD) data are shown in Table 1. The results show that all of the sulphonamides were somewhat low but still at acceptable recoveries (average of 77.8%) and good precision (average of 7.2% RSD). Samples were concentrated during the procedure to optimize sensitivity, which also caused additional matrix effects that possibly contributed to a higher RSD of target compounds at low levels.
Table 1: Recovery and repeatability of sulphonamides in fortified liver homogenate.
When compared to other sample preparation methods, such as LLE and SPE, QuEChERS methodology is easy, fast, low cost and does not require automation. In addition, it is labour saving and a 'greener' technology. The recovery and reproducibility, based on matrix-spiked standards, were acceptable for multiresidue sulphonamide determination in bovine liver. The impurities and matrix effects from liver were minimal and did not interfere with the quantification of any target compound. The LOQs of the quinolones were much lower than their regulated MRLs in animal food products (20–100 ng/g). This modified QuEChERS procedure is a very promising methodology for the quantitative analysis of sulphonamides in food products of animal origin. This application demonstrates great potential of SampliQ QuEChERS extraction and dispersive-SPE kits, and extend far beyond plant matrices to bio-matrices, such as animal food products and bio-fluid.
Agilent SampliQ QuEChERS EN Extraction kit p/n 5982-5650. Agilent SampliQ QuEChERS EN fatty dispersive-SPE kit for 15 mL p/n 5982-5156.
The complete text of this application first appeared as Agilent Technologies publication 5990-5086EN.
Agilent Technologies Inc.
2850 Centerville Road, Wilmington, Delaware 19808, USA
tel. +1 800 227 9770 fax +1 302 633 8901
Website: www.agilent.com
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.